AC Immune S.A. (ACIU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||
| Net Income | 21,097 | N/A | N/A |
| Depreciation Amortization | 299 | N/A | N/A |
| Accounts payable and accrued liabilities | -147 | N/A | N/A |
| Other Working Capital | 25,587 | N/A | N/A |
| Other Operating Activity | -953 | 0 | 0 |
| Operating Cash Flow | $45,883 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -254 | N/A | N/A |
| Investing Cash Flow | $-254 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 91 | N/A | N/A |
| Other Financing Activity | 28,821 | 0 | 0 |
| Financing Cash Flow | $28,911 | $N/A | $N/A |
| Exchange Rate Effect | 1,663 | N/A | N/A |
| Beginning Cash Position | 3,441 | N/A | N/A |
| End Cash Position | 79,644 | N/A | N/A |
| Net Cash Flow | $76,203 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | 45,883 | N/A | N/A |
| Capital Expenditure | -254 | N/A | N/A |
| Free Cash Flow | 45,629 | 0 | 0 |